November 22 – A new study on insulin access for people living with diabetes predicts that 40 million people with diabetes will be without the vital drug by 2030, particularly in Africa, Asia and Oceania.
As the number of people living with diabetes continues to increase, access to insulin needed to meet growing demand will be reduced, according to research published in the journal Lancet Diabetes and Endocrinology.
Diabetes, which can lead to blindness, kidney failure, heart problems, neuropathic pain and amputations, currently affects 9% of adults worldwide, an increase of 5% over 1980 levels.
The researchers said that the demand for insulin needed to effectively treat type 2 diabetes will increase by more than 20 percent in the next 12 years but that insulin will be out of reach of half of the 79 million type 2 diabetics. will need in 2030.
By 2030, 79 million adults with type 2 diabetes are expected to need insulin to control their condition, and if current levels of access are maintained, only half of them will be able to get an adequate supply, according to the Helmsley-funded study Charitable. Confidence.
Access to the drug should be significantly improved, the researchers warn, particularly in the regions of Africa, Asia and Oceania, which will be most affected.
"These estimates suggest that current levels of insulin access are very inadequate compared to projected needs, particularly in Africa and Asia, and more efforts should be devoted to overcoming this imminent health challenge," said Sanjay Basu. Professor of Medicine at Stanford, who led the research.
"Despite the United Nations commitment to treat noncommunicable diseases and ensure universal access to diabetes medicines, in much of the world insulin is scarce and difficult to access for patients," he recalled.